364 related articles for article (PubMed ID: 20937043)
1. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
Gustavsson A; Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Magnuson A; Halfvarson J; Tysk C
Aliment Pharmacol Ther; 2010 Oct; 32(8):984-9. PubMed ID: 20937043
[TBL] [Abstract][Full Text] [Related]
2. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
3. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Jakobovits SL; Jewell DP; Travis SP
Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
[TBL] [Abstract][Full Text] [Related]
4. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
5. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
[TBL] [Abstract][Full Text] [Related]
6. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C
Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
8. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
Mocciaro F; Orlando A; Scimeca D; Cottone M
Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
[TBL] [Abstract][Full Text] [Related]
9. Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.
Halpin SJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2010 Nov; 32(10):1294-5. PubMed ID: 20955450
[No Abstract] [Full Text] [Related]
10. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Sandborn WJ; Rutgeerts P; Feagan BG; Reinisch W; Olson A; Johanns J; Lu J; Horgan K; Rachmilewitz D; Hanauer SB; Lichtenstein GR; de Villiers WJ; Present D; Sands BE; Colombel JF
Gastroenterology; 2009 Oct; 137(4):1250-60; quiz 1520. PubMed ID: 19596014
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
[TBL] [Abstract][Full Text] [Related]
12. Infliximab for the treatment of acute exacerbations of ulcerative colitis.
Bryan S; Andronis L; Hyde C; Connock M; Fry-Smith A; Wang D
Health Technol Assess; 2010 May; 14 Suppl 1():9-15. PubMed ID: 20507798
[TBL] [Abstract][Full Text] [Related]
13. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization.
Oussalah A; Evesque L; Laharie D; Roblin X; Boschetti G; Nancey S; Filippi J; Flourié B; Hebuterne X; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 Dec; 105(12):2617-25. PubMed ID: 20736936
[TBL] [Abstract][Full Text] [Related]
14. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
[TBL] [Abstract][Full Text] [Related]
15. Infliximab for ulcerative colitis following liver transplantation.
Lal S; Steinhart AH
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
[TBL] [Abstract][Full Text] [Related]
16. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
[TBL] [Abstract][Full Text] [Related]
17. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
[TBL] [Abstract][Full Text] [Related]
18. Management of acute severe ulcerative colitis.
Van Assche G; Vermeire S; Rutgeerts P
Gut; 2011 Jan; 60(1):130-3. PubMed ID: 21030524
[TBL] [Abstract][Full Text] [Related]
19. Is keeping the colon the ultimate marker of success in ulcerative colitis?
Nguyen GC; Prather CM
Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
[No Abstract] [Full Text] [Related]
20. Infliximab in the treatment of severe ulcerative colitis: a follow-up study.
Kohn A; Prantera C; Pera A; Cosintino R; Sostegni R; Daperno M
Eur Rev Med Pharmacol Sci; 2004; 8(5):235-7. PubMed ID: 15638237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
